R01 CA200787/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2016	1
2017	1
2018	1
2020	2
2021	4
2023	1
2024	0

1

Overcoming oncogene addiction in breast and prostate cancers: a comparative mechanistic overview.

Blatt EB, Kopplin N, Kumar S, Mu P, Conzen SD, Raj GV. Blatt EB, et al. Endocr Relat Cancer. 2021 Feb;28(2):R31-R46. doi: 10.1530/ERC-20-0272. Endocr Relat Cancer. 2021. PMID: 33263560 Free PMC article. Review.

2

Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations.

Yenerall P, Kollipara RK, Avila K, Peyton M, Eide CA, Bottomly D, McWeeney SK, Liu Y, Westover KD, Druker BJ, Minna JD, Kittler R. Yenerall P, et al. Cancer Res. 2021 Sep 15;81(18):4685-4695. doi: 10.1158/0008-5472.CAN-21-1153. Epub 2021 Jul 23. Cancer Res. 2021. PMID: 34301758 Free PMC article.

3

Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer.

Wang S, Ekoue DN, Raj GV, Kittler R. Wang S, et al. Cancer Lett. 2018 Dec 1;438:86-96. doi: 10.1016/j.canlet.2018.09.010. Epub 2018 Sep 11. Cancer Lett. 2018. PMID: 30217566 Free PMC article. Review.

4

Global chromatin landscapes identify candidate noncoding modifiers of cardiac rhythm.

Bhattacharyya S, Kollipara RK, Orquera-Tornakian G, Goetsch S, Zhang M, Perry C, Li B, Shelton JM, Bhakta M, Duan J, Xie Y, Xiao G, Evers BM, Hon GC, Kittler R, Munshi NV. Bhattacharyya S, et al. J Clin Invest. 2023 Feb 1;133(3):e153635. doi: 10.1172/JCI153635. J Clin Invest. 2023. PMID: 36454649 Free PMC article.

5

Mithramycin suppresses DNA damage repair via targeting androgen receptor in prostate cancer.

Wang S, Gilbreath C, Kollipara RK, Sonavane R, Huo X, Yenerall P, Das A, Ma S, Raj GV, Kittler R. Wang S, et al. Cancer Lett. 2020 Sep 28;488:40-49. doi: 10.1016/j.canlet.2020.05.027. Epub 2020 May 30. Cancer Lett. 2020. PMID: 32485222 Free PMC article.

6

Structure-based classification of EGFR mutations informs inhibitor selection for lung cancer therapy.

Yenerall P, Kittler R, Minna J. Yenerall P, et al. Cancer Cell. 2021 Nov 8;39(11):1455-1457. doi: 10.1016/j.ccell.2021.10.012. Epub 2021 Nov 8. Cancer Cell. 2021. PMID: 34752753 Free PMC article.

7

The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer.

Wang S, Kollipara RK, Humphries CG, Ma SH, Hutchinson R, Li R, Siddiqui J, Tomlins SA, Raj GV, Kittler R. Wang S, et al. Oncotarget. 2016 Oct 4;7(40):64921-64931. doi: 10.18632/oncotarget.11915. Oncotarget. 2016. PMID: 27626314 Free PMC article.

8

Dynamic differences between DNA damage repair responses in primary tumors and cell lines.

Gilbreath C, Ma S, Yu L, Sonavane R, Roggero CM, Devineni A, Mauck R, Desai NB, Bagrodia A, Kittler R, Raj GV, Yin Y. Gilbreath C, et al. Transl Oncol. 2021 Jan;14(1):100898. doi: 10.1016/j.tranon.2020.100898. Epub 2020 Oct 20. Transl Oncol. 2021. PMID: 33096336 Free PMC article.

9

Androgen Receptor Variants Mediate DNA Repair after Prostate Cancer Irradiation.

Yin Y, Li R, Xu K, Ding S, Li J, Baek G, Ramanand SG, Ding S, Liu Z, Gao Y, Kanchwala MS, Li X, Hutchinson R, Liu X, Woldu SL, Xing C, Desai NB, Feng FY, Burma S, de Bono JS, Dehm SM, Mani RS, Chen BPC, Raj GV. Yin Y, et al. Cancer Res. 2017 Sep 15;77(18):4745-4754. doi: 10.1158/0008-5472.CAN-17-0164. Epub 2017 Jul 28. Cancer Res. 2017. PMID: 28754673 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year